Viral persistence: HIV's strategies of immune system evasion.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Annual Review of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/ANNUREV.MED.53.082901.104053PMID 11818487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The antiviral activity of antibodies in vitro and in vivo

  2004cited by this paper
• The challenge of viral reservoirs in HIV-1 infection.

  2002cited by this paper
• Ability of the V3 Loop of Simian Immunodeficiency Virus To Serve as a Target for Antibody-Mediated Neutralization: Correlation of Neutralization Sensitivity, Growth in Macrophages, and Decreased Dependence on CD4

  2001cited by this paper
• Relationships between CD4 Independence, Neutralization Sensitivity, and Exposure of a CD4-Induced Epitope in a Human Immunodeficiency Virus Type 1 Envelope Protein

  2001cited by this paper
• Reversal of Human Immunodeficiency Virus Type 1 IIIB to a Neutralization-Resistant Phenotype in an Accidentally Infected Laboratory Worker with a Progressive Clinical Course

  2001cited by this paper
• Increased Neutralization Sensitivity of CD4-Independent Human Immunodeficiency Virus Variants

  2001cited by this paper
• Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

  2000cited by this paper
• Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection

  2000cited by this paper
• Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.

  2000cited by this paper
• Immune control of HIV-1 after early treatment of acute infection

  2000cited by this paper
• Quantifying the uncertainty in forecasts of anthropogenic climate change

  2000cited by this paper
• AIDS: Escape from the immune system

  2000cited by this paper
• Definition of Five New Simian Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitopes and Their Restricting Major Histocompatibility Complex Class I Molecules: Evidence for an Influence on Disease Progression

  2000cited by this paper
• Interactions of HIV-1 NEF with cellular signal transducing proteins.

  2000cited by this paper
• Downregulation of Major Histocompatibility Complex Class I Molecules by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins

  2000cited by this paper
• Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

  2000cited by this paper
• Sensitivity to a Nonpeptidic Compound (RPR103611) Blocking Human Immunodeficiency Virus Type 1 Env-Mediated Fusion Depends on Sequence and Accessibility of the gp41 Loop Region

  2000cited by this paper
• Simian and Human Immunodeficiency Virus Nef Proteins Use Different Surfaces To Downregulate Class I Major Histocompatibility Complex Antigen Expression

  2000cited by this paper
• Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis.

  2000cited by this paper
• HIV-1 Membrane Fusion

  2000cited by this paper
• HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

  1999cited by this paper
• Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef

  1999cited by this paper
• Nef-Induced CD4 and Major Histocompatibility Complex Class I (MHC-I) Down-Regulation Are Governed by Distinct Determinants: N-Terminal Alpha Helix and Proline Repeat of Nef Selectively Regulate MHC-I Trafficking

  1999cited by this paper
• Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.

  1999cited by this paper
• Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.

  1999cited by this paper
• Selection for Neutralization Resistance of the Simian/Human Immunodeficiency Virus SHIVSF33A Variant In Vivo by Virtue of Sequence Changes in the Extracellular Envelope Glycoprotein That Modify N-Linked Glycosylation

  1999cited by this paper
• Two elements target SIV Nef to the AP‐2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis

  1999cited by this paper
• Structural basis for membrane fusion by enveloped viruses.

  1999cited by this paper
• Adaptation of a CCR5-Using, Primary Human Immunodeficiency Virus Type 1 Isolate for CD4-Independent Replication

  1999cited by this paper
• Primary Virus Envelope Cross-Reactivity of the Broadening Neutralizing Antibody Response during Early Chronic Human Immunodeficiency Virus Type 1 Infection

  1999cited by this paper
• Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors.

  1999cited by this paper
• HIV's evasion of the cellular immune response

  1999cited by this paper
• Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys

  1999cited by this paper
• The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

  1999cited by this paper
• Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.

  1999cited by this paper
• Mechanism of Nef‐induced CD4 endocytosis: Nef connects CD4 with the μ chain of adaptor complexes

  1998cited by this paper
• HIV-1 Variation Diminishes CD4 T Lymphocyte Recognition

  1998cited by this paper
• The antigenic structure of the HIV gp120 envelope glycoprotein

  1998cited by this paper
• Viral dynamics in HIV-1 infection.

  1998cited by this paper
• A role for carbohydrates in immune evasion in AIDS

  1998cited by this paper
• HIV-1: fifteen proteins and an RNA.

  1998cited by this paper
• HIV entry and its inhibition.

  1998cited by this paper
• The SH3 domain‐binding surface and an acidic motif in HIV‐1 Nef regulate trafficking of class I MHC complexes

  1998cited by this paper
• Mutations in both gp120 and gp41 Are Responsible for the Broad Neutralization Resistance of Variant Human Immunodeficiency Virus Type 1 MN to Antibodies Directed at V3 and Non-V3 Epitopes

  1998cited by this paper
• Identification of Highly Attenuated Mutants of Simian Immunodeficiency Virus

  1998cited by this paper
• Viral strategies of immune evasion.

  1998cited by this paper
• Human Immunodeficiency Virus (HIV) Envelope Binds to CXCR4 Independently of CD4, and Binding Can Be Enhanced by Interaction with Soluble CD4 or by HIV Envelope Deglycosylation

  1998cited by this paper
• CD4-Induced Conformational Changes in the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein: Consequences for Virus Entry and Neutralization

  1998cited by this paper
• The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.

  1998cited by this paper
• Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: isolation of a neutralization escape variant.

  1998cited by this paper
• Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules.

  1998cited by this paper
• An Envelope Modification That Renders a Primary, Neutralization-Resistant Clade B Human Immunodeficiency Virus Type 1 Isolate Highly Susceptible to Neutralization by Sera from Other Clades

  1998cited by this paper
• HIV type 1-specific helper T cells: a critical host defense.

  1998cited by this paper
• Spontaneous Mutations in the env Gene of the Human Immunodeficiency Virus Type 1 NDK Isolate Are Associated with a CD4-Independent Entry Phenotype

  1998cited by this paper
• Selection of Virus Variants and Emergence of Virus Escape Mutants after Immunization with an Epitope Vaccine

  1998cited by this paper
• Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

  1998cited by this paper
• HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes

  1998cited by this paper
• Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

  1997cited by this paper
• CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry.

  1997cited by this paper
• Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

  1997cited by this paper
• HIV-1 Nef and host cell protein kinases.

  1997cited by this paper
• Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

  1997cited by this paper
• HIV-1 antibody — debris or virion?

  1997cited by this paper
• Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.

  1997cited by this paper
• Reverse Transcriptase and the Generation of Retroviral DNA

  1997cited by this paper
• Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein

  1997cited by this paper
• Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies

  1997cited by this paper
• A vaccine for HIV type 1: the antibody perspective.

  1997cited by this paper
• Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

  1997cited by this paper
• Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off

  1997cited by this paper
• Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1

  1997cited by this paper
• Co‐localization of HIV‐1 Nef with the AP‐2 adaptor protein complex correlates with Nef‐induced CD4 down‐regulation

  1997cited by this paper
• Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

  1997cited by this paper
• Escape of human immunodeficiency virus from immune control.

  1997cited by this paper
• CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain.

  1997cited by this paper
• CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

  1996cited by this paper
• Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1.

  1996cited by this paper
• A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation.

  1996cited by this paper
• High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection

  1996cited by this paper
• Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites

  1996cited by this paper
• Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

  1996cited by this paper
• Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein

  1996cited by this paper
• Endogenous ecotropic and recombinant MCF mouse retroviral variation and escape from antiviral CTL

  1996cited by this paper
• Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer.

  1996cited by this paper
• Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

  1995cited by this paper
• Change in tropism upon immune escape by human immunodeficiency virus

  1995cited by this paper
• Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120

  1995cited by this paper
• HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

  1995cited by this paper
• Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

  1995cited by this paper
• Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression

  1995cited by this paper
• Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein

  1995cited by this paper
• Protection against HIV‐1 infection in hu‐PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4‐binding site

  1995cited by this paper
• Epitope exposure on functional, oligomeric HIV-1 gp41 molecules.

  1995cited by this paper
• Viral dynamics in human immunodeficiency virus type 1 infection

  1995cited by this paper
• Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

  1995cited by this paper
• Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes

  1995cited by this paper
• Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients

  1995cited by this paper
• Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

  1995cited by this paper
• Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence.

  1994cited by this paper
• Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change

  1994cited by this paper

• Avian leukosis virus subgroup J evades innate immunity by activating miR-155 to dually target TRAF3 and STAT1

  2025cites this paper
• Cell therapies for viral diseases: a new frontier

  2025cites this paper
• Torque teno viruses exhaust and imprint the human immune system via the HLA-E/NKG2A axis

  2024cites this paper
• Chronic HIV Transcription, Translation, and Persistent Inflammation

  2024cites this paper
• Easing genomic surveillance: A comprehensive performance evaluation of long-read assemblers across multi-strain mixture data of HIV-1 and Other pathogenic viruses for constructing a user-friendly bioinformatic pipeline

  2024cites this paper
• Espektro zabaleko antigorputzen rola GIBaren aurkako terapian eta prebentzioan

  2023cites this paper
• HIV-1 entry: Duels between Env and host antiviral transmembrane proteins on the surface of virus particles.

  2021cites this paper
• Adjuvant‐mediated enhancement of the immune response to HIV vaccines

  2021cites this paper
• The Immunoproteasome: An Emerging Target in Cancer, Autoimmune and Neurological Disorders.

  2020cites this paper
• Production and evaluating the properties of HIV-1-Nef-MPER-V3 fusion protein harboring IMT-P8 cell penetrating peptide.

  2020cites this paper
• Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4+ T Cells

  2019cites this paper
• Structural Insights from HIV-Antibody Coevolution and Related Immunization Studies

  2018cites this paper
• Characterizing Immune Response to HIV-1 Infection in BICD2-Knockout Cells

  2018cites this paper
• Das Versagen der Immunantwort

  2018cites this paper
• High-Resolution Sequencing of Viral Populations during Early Simian Immunodeficiency Virus Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses

  2018cites this paper
• Characterisation of HIV-1 subtype C envelope functional determinants of dual infected individuals

  2018cites this paper
• CHARACTERIZATION OF APOBEC3 REPERTOIRES AND EFFECTS ON RETROVIRAL REPLICATION

  2018cites this paper
• Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design

  2018cites this paper
• The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice

  2018cites this paper
• Quantifying how the mutational tolerance of HIV's envelope protein shapes its evolution

  2017cites this paper
• Variation in the dynamics and performance of industrial innovation: what can we learn from vaccines and HIV vaccines?

  2017cites this paper
• New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV.

  2017cites this paper
• Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections

  2017cites this paper
• Experimental Estimation of the Effects of All Amino-Acid Mutations to HIV’s Envelope Protein on Viral Replication in Cell Culture

  2016cites this paper
• Synthese und Charakterisierung von modifizierten Peptiden und Glycopeptiden aus der V3-Region des gp120 aus HIV

  2016cites this paper
• The generation of domainspeccific monoclonal anti-CD4 antibodies as novel candidate HIV therapies

  2016influential citation
• STABILIZATION OF GP120 OUTER DOMAIN FOR HIV-1-1 VACCINE IMMUNOGEN DESIGN

  2016cites this paper
• Experimental estimation of the effects of all amino-acid mutations to HIV Env

  2016cites this paper
• Identifying possible sites for antibody neutralization escape: Implications for unique functional properties of the C-terminal tail of Human Immunodeficiency Virus Type 1 gp41.

  2016cites this paper
• Adaptive Evolution of the SIV Envelope Protein During Early SIV Infection

  2016influential citation
• Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late

  2016cites this paper
• Overlapping Regions in HIV-1 Genome Act as Potential Sites for Host–Virus Interaction

  2016cites this paper
• The Transmembrane Domain of HIV-1 gp41 Inhibits T-Cell Activation by Targeting Multiple T-Cell Receptor Complex Components through Its GxxxG Motif.

  2016cites this paper
• Mechanisms of MPER helix binding at membrane interfaces and implications for the broad neutralization of HIV by antibodies

  2016cites this paper
• Designing synthetic vaccines for HIV

  2015cites this paper
• Epithelial stem cells as mucosal antigen-delivering cells: A novel AIDS vaccine approach.

  2015cites this paper
• Impaired memory B cell IgG isotype switching and circulating T follicular-helper cell dysfunction in patients with chronic HIV-1 infection

  2015cites this paper
• Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response

  2015cites this paper
• Explaining Variation in Medical Innovation: The Case of Vaccines, and the HIV AIDS effort

  2015cites this paper
• Visualization and quantification of simian immunodeficiency virus-infected cells using non-invasive molecular imaging.

  2015cites this paper
• Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif

  2015cites this paper
• IL-10-Producing B Cells Are Induced Early in HIV-1 Infection and Suppress HIV-1-Specific T Cell Responses

  2014cites this paper
• Characterization and Development of a Novel Cytomegalovirus for Evaluation as an HIV Vaccine Viral Vector in a Non-Human Primate Model

  2014cites this paper
• Structure of 2G12 Fab2 in Complex with Soluble and Fully Glycosylated HIV-1 Env by Negative-Stain Single-Particle Electron Microscopy

  2014cites this paper
• Antigen-specific immune modulation using an injectable biomaterial

  2014cites this paper
• Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus

  2014cites this paper
• Low-frequency variant detection in viral populations using massively parallel sequencing data

  2014influential citation
• Establishment and evaluation of a feline foamy virus subviral particle-based vaccine strategy for induction of neutralizing antibodies against HIV-1

  2014cites this paper
• Programmed Death Ligand 2 Gene Regulation in T-cells During Homeostasis and Lentiviral Infection

  2014influential citation
• Microscopyn Single-Particle Electron Soluble and Fully Glycosylated HIV-1 Env in Complex with 2 Structure of 2G12 Fab

  2014cites this paper
• On the redox biology of the immuno-virological receptor CD4: biological function and applications in HIV-1 drug and vaccine development

  2014cites this paper
• A imunodeficiência e o sistema imunitário: O comportamento em portadores de HIV

  2014cites this paper
• Emergence of speciation in host-pathogen coevolution

  2013cites this paper
• Modulation of Tumor Immunity by Soluble and Membrane-Bound Molecules at the Immunological Synapse

  2013cites this paper
• Equivalent T Cell Epitope Promiscuity in Ecologically Diverse Human Pathogens

  2013cites this paper
• A Modern Biopharmaceutical to Treat AIDS – Challenges in Designing HIV Env Immunogens for Developing a Vaccine

  2013cites this paper
• Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9

  2013cites this paper
• Limited conformational flexibility in the paratope may be responsible for degenerate specificity of HIV epitope recognition.

  2013cites this paper
• HIV-1 fusion protein exerts complex immunosuppressive effects.

  2013cites this paper
• THE IDENTIFICATION OF BIOLOGICALLY IMPORTANT SECONDARY STRUCTURES IN DISEASE-CAUSING RNA VIRUSES

  2013cites this paper
• 51 – Human immunodeficiency virus vaccines

  2013cites this paper
• An Overview of the Immune Evasion Strategies Adopted by Different Viruses with Special Reference to Classical Swine Fever Virus

  2013cites this paper
• Coevolutionary Immune System Dynamics Driving Pathogen Speciation

  2013cites this paper
• Gene expression pattern and functional analysis of CD8+ T cells from individuals with or without anti HIV/SIV noncytolytic activity.

  2012cites this paper
• Evolutionary dynamics of HIV at multiple spatial and temporal scales

  2012cites this paper
• HIV vaccine design based on in vivo evolution of quasispecies envelope proteins

  2012cites this paper
• Evaluation of Cynomolgus Macaque (Macaca fascicularis) Endogenous Retrovirus Expression Following Simian Immunodeficiency Virus Infection

  2012cites this paper
• Expansion of Variant Diversity Associated with a High Prevalence of Pathogen Strain Superinfection under Conditions of Natural Transmission

  2012cites this paper
• Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A Streptococcus.

  2012cites this paper
• The role of IL-15 in challenging Acquired Immunodeficiency Syndrome.

  2012cites this paper
• Human immunodeficiency virus vaccine trials.

  2012cites this paper
• Selection and Analysis of HIV-1 Envelope Epitopes for Design of Vaccines that can Induce Broadly Neutralizing Antibodies

  2012cites this paper
• A Novel Assay for Antibody-Dependent Cell-Mediated Cytotoxicity against HIV-1- or SIV-Infected Cells Reveals Incomplete Overlap with Antibodies Measured by Neutralization and Binding Assays

  2012cites this paper
• The identification of biologically important secondary structures in disease-causing RNA viruses.

  2012cites this paper
• Structural insights into key sites of vulnerability on HIV‐1 Env and influenza HA

  2012cites this paper
• Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing

  2012cites this paper
• The Immunosuppressive Role of IL-32 in Lymphatic Tissue during HIV-1 Infection

  2011cites this paper
• Addendum: Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

  2011cites this paper
• Lymphatic Tissue during HIV-1 Infection The Immunosuppressive Role of IL-32 in

  2011cites this paper
• Une radiothérapie interne contre l’infection au VIH, la dernière pièce du puzzle ?

  2011cites this paper
• Antibody Evasion by a Gammaherpesvirus O-Glycan Shield

  2011cites this paper
• Vaccinology: Persistence pays off

  2011cites this paper
• Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry.

  2011cites this paper
• Structural Characterization of the anti-HIV-1 Broadly Neutralizing Monoclonal Antibody 2F5

  2011cites this paper
• Cyclin K Inhibits HIV-1 Gene Expression and Replication by Interfering with Cyclin-dependent Kinase 9 (CDK9)-Cyclin T1 Interaction in Nef-dependent Manner*

  2011cites this paper
• Vaccine Protection against Simian Immunodeficiency Virus in Monkeys Using Recombinant Gamma-2 Herpesvirus

  2011cites this paper
• Polyvalent AIDS vaccines.

  2010cites this paper
• Reduction of HIV-virion Transport for Prevention of HIV Transmission

  2010cites this paper
• Human immunodeficiency virus type 1 evasion of a neutralizing anti-V3 antibody involves acquisition of a potential glycosylation site in V2.

  2010cites this paper
• Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses.

  2010cites this paper
• Enhanced Exposure of Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Epitopes through Binding of CD4 Mimetic Compounds

  2010cites this paper
• Knowledge accumulation and vaccine innovation: lessons from polio and HIV/AIDS

  2010cites this paper
• A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity

  2010cites this paper
• Human immunodeficiency virus type 1 evasion of a neutralizing anti-V 3 antibody involves acquisition of a potential glycosylation site in V 2

  2010cites this paper
• Helicobacter pylori's Unconventional Role in Health and Disease

  2009cites this paper
• Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies

  2009cites this paper
• The role of HIV- and SIV-specific CD8+ T cells in the establishment of persistent HIV and SIV infections.

  2009influential citation
• Title Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins : Implications for evasion of immune responses and design of vaccine

  2009cites this paper
• Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens

  2009cites this paper
• C Virologic tools for neutralization assays Ochsenbauer and Kappes 419 First-generation neutralizing antibody assays

  2009cites this paper